Corvus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.About CRVS
Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody.
CRVS Key Statistics
Stock Snapshot
With a market cap of 904.27M, Corvus Pharmaceuticals(CRVS) trades at $10.72. The stock has a price-to-earnings ratio of -14.88.
On 2026-11-16, Corvus Pharmaceuticals(CRVS) stock traded between a low of $10.51 and a high of $11.05. Shares are currently priced at $10.72, which is +2.0% above the low and -3.0% below the high.
Corvus Pharmaceuticals(CRVS) shares are trading with a volume of 179.88K, against a daily average of 1.04M.
During the past year, Corvus Pharmaceuticals(CRVS) stock moved between $6.39 at its lowest and $26.95 at its peak.
During the past year, Corvus Pharmaceuticals(CRVS) stock moved between $6.39 at its lowest and $26.95 at its peak.
CRVS News
Corvus Pharmaceuticals Inc. ((CRVS)) has held its Q3 earnings call. Read on for the main highlights of the call. Corvus Pharmaceuticals delivered a largely pos...
...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.